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ABSTRACT Ligand-induced receptor aggregation is a well-known mechanism for initiating intracellular signals but oligomeri-
zation of distal signaling molecules may also be required for signal propagation. Formation of complexes containing oligomers of
the transmembrane adaptor protein, linker for the activation of T cells (LAT), has been identiﬁed as critical in mast cell and T cell
activation mediated by immune response receptors. Cross-linking of LAT arises from the formation of a 2:1 complex between the
adaptor Grb2 and the nucleotide exchange factor SOS1, which bridges two LAT molecules through the interaction of the Grb2
SH2 domain with a phosphotyrosine on LAT. We model this oligomerization and ﬁnd that the valence of LAT for Grb2, which
ranges from zero to three, is critical in determining the nature and extent of aggregation. A dramatic rise in oligomerization
can occur when the valence switches from two to three. For valence three, an equilibrium theory predicts the possibility of forming
a gel-like phase. This prediction is conﬁrmed by stochastic simulations, which make additional predictions about the size of the
gel and the kinetics of LAT oligomerization. We discuss the model predictions in light of recent experiments on RBL-2H3 and
Jurkat E6.1 cells and suggest that the gel phase has been observed in activated mast cells.INTRODUCTION
Ligand-induced receptor aggregation is a ubiquitous method
for triggering intracellular signals. The growth factor recep-
tors (1), the cytokine receptors (2), and the immune recogni-
tion receptors (with the possible exception of the T cell
receptor (TCR)) (3) all initiate signaling in this way. Within
these families, multiple mechanisms have been elucidated by
which ligands promote the aggregation of their cognate
receptors and cause the cytoplasmic domains of the aggre-
gated receptors to remain in proximity for times much longer
than random motions of diffusing receptors permit. The role
of aggregation in cell signaling is not confined to bringing
together the cytoplasmic domains of receptors. Aggregation
of nonreceptor molecules also play a role in propagating the
cell-signaling cascade. Here, we focus on the aggregation of
a scaffolding protein, the linker for the activation of T cells
(LAT), which is essential for full mast cell and T cell func-
tion (4). The aggregation of LAT differs from the aggrega-
tion of receptors by external ligands in a fundamental
way—LAT has a variable valence for binding the complex
that induces its aggregation depending on the number of
binding-site tyrosines that are phosphorylated.
LAT, which is localized primarily in microdomains (5),
can be thought of as a major signaling hub in the signaling
networks initiated by the activation of the high affinity
receptor for IgE (Fc3RI) on mast cells and the TCR on
T cells. LAT is a single-chain transmembrane protein whose
cytoplasmic domain contains nine tyrosines conserved
among mouse, rat, and human (6,7). The distal four LAT
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tion (9). The distal three tyrosines are located in motifs of the
form YXNX that bind the SH2 domain of the adaptor Grb2
when phosphorylated (10). Thus, the valence of LAT for
Grb2 can vary from zero to three, depending on the number
of phosphorylated LAT tyrosines.
Grb2 mediates the recruitment of the nucleotide exchange
factor Son of sevenless-1 (SOS1) from the cytosol to the
plasma membrane where it activates Ras by inducing the
exchange of GDP for GTP (11,12). Grb2 contains one
SH2 domain flanked on each side by a Src homology 3
(SH3) domain (13,14) (see Fig. 1). The two SH3 domains
of Grb2 bind to proline-rich regions on SOS1 to form
a 1:1 Grb2-SOS1 complex. A second Grb2 can bind through
both its SH3 domains to this complex to form a Grb2-SOS1-
Grb2 dimer that is capable of bridging two phosphorylated
LAT molecules (15) (see Fig. 2). The interaction of this biva-
lent ligand (Grb2-SOS1-Grb2) with a trivalent scaffolding
protein (LAT with its three distal tyrosines phosphorylated)
can induce formation of large aggregates. The formation of
large clusters of LAT has been observed in T cells following
T cell engagement (15,16) and in mast cells following the
aggregation of IgE-Fc3RI complexes (17,18).
Previously, an equilibrium theory for the binding of triva-
lent ligands to bivalent receptors was developed to study
cross-linking of IgE on the surface of mast cells (19). One
interesting prediction of the theory was that for a range of
ligand and receptor concentrations, extremely large aggre-
gates, i.e., superaggregates, could form on the cell surface.
The theory predicted that if the receptor concentration
were high enough, then as the ligand concentration was
increased a critical ligand concentration would be reached
where superaggregates would form, corresponding to a
doi: 10.1016/j.bpj.2009.01.019
Modeling LAT Oligomerization 2605sol-gel phase transition. Superaggregates do not form for
ligands with a valence of one or two interacting with bivalent
receptors. Upon exposure to ligands of valence greater than
two, gel-like formation was observed on liposomes into
which high densities of mobile receptors were inserted
(20,21). In the case of LAT, these results suggest that a similar
phase transition could arise from valence-switching brought
about by increased LAT phosphorylation in response to
ligand-induced receptor aggregation. However, there are
significant differences between the two systems beyond
LAT aggregation occurring on the plasma membrane’s inner
surface and receptor aggregation occurring on its outer
surface. When fully phosphorylated, LAT acts as a trivalent
receptor for the SH2 domain of Grb2, but Grb2 is present in
three forms that can bind LAT—two monovalent (Grb2 and
Grb2-SOS1) and one bivalent (Grb2-SOS1-Grb2)—the
FIGURE 1 Model for the interactions of Grb2 with SOS1 and the forma-
tion of a Grb2-SOS1-Grb2 dimer. For Grb2 to form a stable complex with
SOS1, both SH3 domains of Grb2 must simultaneously bind to SOS1.
The value s is the factor by which the presence of a Grb2 bound to SOS1
reduces the equilibrium constant for the binding of the second Grb2 to
SOS1. The value l is the length of a Grb2 and d is the length between the
SH2 domains of Grb2 in a Grb2-SOS1-Grb2 dimer.relative and absolute concentrations of which change in
response to LAT phosphorylation (15).
Here, we present a chemical kinetic model for the oligo-
merization of LAT mediated by interaction with the 2:1
Grb2:SOS1 complex. We solve the model using two
methods that complement each other. Following Goldstein
and Perelson (19), we develop an analytic equilibrium theory
that allows us to predict the equilibrium LAT oligomer size
distribution, given the total cellular concentrations of LAT,
Grb2, and SOS1. We also use the theory to map the bound-
aries of the sol-gel concentration space to give us precise
predictions of the conditions under which superaggregates
can form. The equilibrium theory is exact for an infinite
system, but for a system with a finite number of particles,
such as a cell, the question arises whether the effects of finite
system size (e.g., an upper limit on the number of molecules
in a superaggregate) will lead to significant deviations from
the continuum limit. Although the equilibrium theory
predicts the fraction of LAT molecules in the sol-gel coexis-
tence region, it makes no prediction about size distribution of
superaggregates. Thus, to check the validity of the equilib-
rium theory, to make additional predictions about the size
distribution of superaggregates, and to follow the kinetics
of LAT oligomerization, we also solve the model using
a kinetic Monte Carlo method designed to simulate well
mixed-biochemical networks governed by rules describing
molecular interactions (22). The equilibrium theory and the
simulation results are in good agreement. Both predict the
formation of superaggregates of LAT over certain concentra-
tion ranges of the interacting components with disparities
arising only at the edges of these ranges.
The organization of the remainder of this article is as
follows. First, we present the model of LAT aggregation
and describe simplifying assumptions. We then describe
the two methods of solution, providing overviews of botha
b
c
d
e
FIGURE 2 Reactions in the oligomerization of LAT.
The dotted ellipse indicates the molecule in the complex
involved in the reaction. Only the C-terminal domain of
SOS1, which contains the binding sites for the SH3
domains of Grb2, is shown. (a) Solution to surface binding:
The binding of a bivalent ligand in solution to a LAT with
two sites free that is at the end of a chain. (b) Surface to
surface cross-linking that extends a chain: The binding of
a free LAT to a Grb2 dimer that is part of a surface
complex. (c) Surface to surface cross-linking that extends
a chain: A bivalent ligand bound to LAT binds through
its free SH2 domain to a free site on a LAT at the end of
a chain. (d) Surface-to-surface cross-linking that adds
a branch to a complex: A bivalent ligand bound to LAT
binds through its free SH2 domain to a free site on
a LAT in the complex. The value rx is a steric hindrance
factor. (e) Surface to surface cross-linking that extends
a chain: A Grb2-LAT complex binds through the free
Grb2 SH3 domain to a SOS1 at the end of a chain.Biophysical Journal 96(7) 2604–2623
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are elaborated in the Appendices and in the Supporting
Material. Finally, we present the results obtained using the
two methods and discuss them in light of recent experiments.
MODEL OF LAT OLIGOMERIZATION
We consider a cell with a cytosolic volume, V, and a surface
area, A. The total number of LAT molecules associated with
the plasma membrane is ALT, while the total number of Grb2
and SOS1 available to interact with LAT and each other are
VGT and VST. The surface concentrations of free LAT, and
the solution concentrations of free Grb2 and SOS1, are L,
G, and S. Their nondimensional concentrations we define
as l ¼ L/LT, g ¼ G/GT, and s ¼ S/ST. The definitions of
the parameters and concentrations used in the article are
listed in Table 1. The model consists of two parts: the inter-
actions in the cytosol between Grb2 and SOS1 (see Fig. 1);
and the interactions at the plasma membrane that lead to the
formation of complexes containing LAT (see Fig. 2).
Formation of Grb2-SOS1-Grb2 dimers
Grb2 is a highly flexible 25 kDa protein that contains an SH2
domain flanked by two SH3 domains (13,14). SOS1 (153
kDa) is a complex multidomain nucleotide exchange factor
that contains a number of proline-rich sequences in its
N-terminal domain that are binding sites for the SH3
domains of Grb2. Fig. 1 shows the kinetic scheme, based
on the Grb2-SOS1 equilibrium binding studies of Houtman
et al. (15), that we use to model the interactions between
Grb2 and SOS1 in the cytosol. For appropriate concentra-
tions, these interactions result in the formation of bivalent
ligands containing two Grb2 SH2 domains that are capable
of bridging two phosphorylated LAT molecules (see
Fig. 1). The equilibrium constant for the binding of the first
Grb2 to a free SOS1 is 2KGS. The binding of a second Grb2
to a 1:1 Grb2-SOS1 complex is taken to be negatively coop-
erative with equilibrium constant sKGS and the cooperativity
factor s< 1 (15). From the law of mass action, it follows that
at equilibrium the concentration of the bivalent ligand Grb2-
SOS1-Grb2 in the cytosol is
C ¼ sK2GSG2S: (1)
We have simplified the dimerization model by assuming that
Grb2, bound through both its SH3 domains to SOS1, is much
more stable than Grb2 bound through a single SH3 domain.
In the binding scheme in Fig. 1, we have therefore ignored
states where Grb2 is bound to SOS1 through a single SH3
domain.
Interactions involving LAT
LAT is a 26-kDa integral membrane protein with nine
conserved tyrosines (6,7). The distal three tyrosines, Y171,Biophysical Journal 96(7) 2604–2623Y191, and Y 226 on human LAT, when phosphorylated,
are binding sites for Grb2 (23,24). Phosphorylated Y171
and Y191 are also binding sites for the adaptor Gads
(8,24); however, in the model we ignore Gads and assume
the only protein that can interact with these sites is Grb2.
We further simplify by treating the three Grb2 binding sites
as identical and noninteracting so that one equilibrium
constant, KGL, describes the binding of a LAT phosphotyro-
sine in a Grb2-binding motif to the SH2 domain of a free
Grb2. (The difference between the smallest and largest equi-
librium constant for the three sites is no greater than a factor
of four (23,25).) Making this equivalent-site approximation
simplifies the equilibrium theory we will develop. We further
simplify the model by assuming the binding properties of the
Grb2 SH2 domain are the same whether Grb2 is free or in
a complex with SOS1. These approximations ignore the
following: that the binding of SOS1 or the SOS1-Grb2
TABLE 1 Glossary of mathematical symbols and terms
Symbol Definition
V Cytosolic volume of the cell.
A Surface area of the cell.
ALT Total number of phosphorylated LAT on the
plasma membrane.
VGT Total number of Grb2 per cell.
VST Total number of SOS1 per cell.
L Surface concentration of LAT with all
phosphorylated sites free.
l ¼ L/LT Fractional concentration of free LAT.
G Cytosolic concentration of Grb2 not bound to
SOS1.
g ¼ G/GT Fractional concentration of free Grbg2.
S Cytosolic concentration of SOS1 not bound to
Grb2.
s ¼ S/ST Fractional concentration of free SOS1.
C Cytosolic concentration of the Grb2-SOS1-Grb2
dimer.
Wn ¼ LTwn Concentration of aggregates containing n LAT
molecules.
w h w1 Fraction of LAT not in aggregates.
wn, m Fraction of LAT in aggregates contain n LAT and
m branch points.
KGS ¼ kþGS/kGS Solution equilibrium binding constant for both
Grb2 SH3 domains to bind to a free SOS1.
s Negative cooperativity factor (see Fig. 1).
sKGS ¼ sKþGS/kGS Solution equilibrium binding constant for both
Grb2 SH3 domains to bind to a SOS1-Grb2
complex.
KGL ¼ kþGL/kGL Solution equilibrium binding constant for a Grb2
SH2 domain to bind to a binding site on LAT.
KGL ¼ kþGL=kGL Surface equilibrium cross-linking constant for
a free end of a Grb2 dimer attached to a LAT to
bind to a binding site on a LAT at the end of
a chain.
rx Steric hindrance factor (see Fig. 2).
rxKGL ¼ rxkþGL=kGL Surface equilibrium branching constant for a free
end of a Grb2 dimer attached to a LAT to bind
to a binding site on another LAT with one site
free and start a new chain.
g Branching parameter defined by Eq. 22.
fg Fraction of LAT in the gel phase.
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for the binding of Grb2 to a singly-phosphorylated LAT;
and that the binding of Grb2-SOS1 to a doubly-phosphory-
lated LAT is positively cooperative (25).
Depending on its state of phosphorylation, a LAT mole-
cule may be mono-, bi-, or trivalent with respect to Grb2.
When mast cells are exposed to an external ligand that causes
the aggregation of Fc3RI on their surface, LAT is rapidly
phosphorylated (17). Similarly for the T cell, aggregation
of the TCR is rapidly followed by LAT phosphorylation
(26). We expect that the number of phosphorylated Grb2
binding sites will change with time and with the concentra-
tion of the external ligand. However, here we only consider
homogeneous populations of phosphorylated LAT, and
compare the oligomerization properties of bi- and trivalent
LAT in the presence of Grb2 and SOS1.
In Fig. 2, a–d, we show various reactions involved in the
oligomerization of LAT: the addition of a bivalent ligand
from solution to aLATcomplex (Fig. 2a); the cross-linking of
a LAT to extend a chain in a LAT complex (Fig. 2, b and c);
and the cross-linking of a LAT to a LAT in the complex
that results in the initiation of a new branch (Fig. 2 c).
At equilibrium, these reactions are characterized by a solu-
tion equilibrium binding constant, KGL, a surface equilib-
rium cross-linking constant, KGL, and a surface equilibrium
branching constant, rxKGL, where rx is a steric hindrance
factor. If rx ¼ 0, the binding of two sites on LAT blocks
the third site and branching cannot occur, whereas if rx ¼ 1,
there is no steric hindrance and cross-linking and branching
have identical equilibrium constants. There are no experi-
ments measuring rx and none that show directly that a single
LAT can bind three Grb2 molecules simultaneously.
However, it has been shown that the three Grb2 binding site
tyrosines as well as two additional tyrosines must be present
on the same LAT molecule to achieve Erk activation (27).
We assume three Grb2 molecules can bind to a single LAT
and take rx ¼ 1.
The reaction in Fig. 2 e introduces the surface equilibrium
cross-linking constant, KGS. From detailed balance, it
follows that
KGS ¼ sðKGL=KGLÞKGS: (2)
For the equilibrium theory, there is no need to introduce this
constant, but for our simulations we will need the rate
constants for this reaction. For the simulations, we will
take kGS ¼ kGS and therefore, kþGS ¼ kGSKGS.
A major assumption of the model is that reactions that lead
to the formation of closed structures (loops) can be ignored.
A special case of this assumption is that the dimer Grb2-
SOS1-Grb2 cannot have its two Grb2 molecules bound
simultaneously through their SH2 domains to the same
LAT molecule. If structures with loops in them have a strong
propensity to form, then the theory we present will overesti-
mate the concentration of large aggregates. In a solution
binding study of a bivalent receptor (IgG) interacting witha synthetic trivalent ligand, small ring formation completely
prevented the formation of large aggregates (28). That does
not appear to be the case for LAT aggregation, because large
aggregates of LAT, i.e., >100 LAT molecules in a cluster,
have been observed in stimulated mast cells (17).
Parameter values
The parameter values of the model are given in Table 2. The
solution equilibrium binding constants for the binding of the
SH3 domains of Grb2 to SOS1 (15,29) and the binding of
Grb2 to its three binding sites on LAT (15,23,25) have
been well studied. Not surprisingly, however, there are no
experimental estimates of the surface equilibrium cross-link-
ing constant KGL, which characterizes the bridging of two
LAT molecules by a Grb2-SOS1-Grb2 dimer. KGL is propor-
tional to KGL because the cross-link is formed when a Grb2
SH2 domain binds to a Grb2 binding site on LAT. If, when
a bivalent ligand has one end bound to a receptor its free end
TABLE 2 Parameters used in the simulations and the
equilibrium model calculations
Parameter Value Reference
V 3.6  1010 cm3 (53)
A 8.0  106 cm2 (53)
s 0.5 (15)
KGL 3.4  106 M1 (15, 23, 25)
kGL 0.31 s
1 (54)
kþGL ¼ kGLKGL 1.1  106 M1 s1
KGS 2.7  106 M1 (15)
kþGS 9.5  104 M1 (29)
kGS ¼ kþGS/KGS 0.03 s1
KGL 1.7  1015 mole1 cm2 *
kGL 0.31 s1
kþGL ¼ kGLKGL 5.3  1014 mole1 cm2 s1
KGS ¼ sðKGL=KGLÞKGS 6.75  1014 mole1 cm2
kGS ¼ kGS 0.31 s1
kþGS ¼ kGSKGS 2.1  1014 mole1 cm2 s1
The equilibrium constants for the binding of Grb2 to one of the three
terminal phosphotyrosines on LAT range from 1–4  106 M1
(15,23,25). In our model the affinities for these three binding sites are iden-
tical. We take KGL ¼ 3.4  106 M1. The value for kGL is from a Biacore
study of the binding of the SH2 domain in a Grb2-SOS1 complex to an
eleven peptide sequence from the cytoplasmic domain of EGFR that
includes the Grb2 binding site pY1068 (54). We assume the dissociation
rate constant is similar for Grb2 dissociating from a phosphorylated site
on LAT. The values of the rate constants have no effect on any equilibrium
results. The dissociation constants for the binding of the Grb2 SH3 domain
to the N-terminal and C-terminal proline-rich regions of SOS1 are 260 nM
and 510 nM, respectively (15). In our model we do not distinguish between
the two SH3 binding sites on SOS1 and take Kd ¼ 364 nM which is close to
the geometric mean of the two values.
*The value of the equilibrium cross-linking constant KGL is estimated from
Eq. 3 by taking d/4 ¼ 200 A˚. To obtain kGL we assume kGL ¼ kGL. The
diameter of the Jurkat cell, 2a, has been measured by Rosenbluth et al. (53)
to be 11.5 mm with the cytosol taking up ~45% of the total cell volume.
V ¼ 0.45  4pa3/3 is the cytosolic volume. The surface area of the Jurkat
cell is taken to be approximately twice the area of a sphere of diameter
11.5 mm. In the stochastic simulations, only unimolecular rate constants can
be used directly so the solution bimolecular rate constants are scaled by the
cytosolic volume V and the surface bimolecular rate constants are scaled by A.Biophysical Journal 96(7) 2604–2623
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stricted way, then an estimate of the surface equilibrium
cross-linking constant is given by (30)
KGL ¼ f KGL
d
; (3)
where f is a constant of order one and d is the effective
length of the cross-linking species Grb2-SOS1-Grb2. From
the Grb2 crystal structure (31), the length of a Grb2 from
its SH2 to its SH3 domain (l in Fig. 1) is ~50 A˚, so that
d ¼ 100 A˚þ (length of the section of SOS1 involved in
the dimer) z150 A˚. Because SOS1 is approximately six
times larger than LAT, we expect that the size of SOS1
will hinder cross-linking and reduce KGL compared with
a single dimeric protein of length d. A larger value of d/f
reduces KGL. To estimate KGL, we take d/f ¼ 200 A˚.
Concentration values
In addition to the values of the parameters, we need to
specify the concentrations of LAT, Grb2, and SOS1 that
are available to interact with each other. For both RBL-
2H3 cells and Jurkat E6.1 cells, it has been estimated that
there are ~1.1  0.1  106 LAT molecules/cell (I. Reischl
and H. Metzger, unpublished results), although not all of
these LATs may be on the plasma membrane. This estimate
places an upper bound on the number of phosphorylated
LATs in our model. Based on four experiments with Grb2
and two with SOS1, the concentration in Jurkat E6.1 cells
of Grb2 was estimated to be 1.3  0.4  106 molecules/
cell and of SOS1 to 1.3  0.4  105 molecules/cell (J. C.
Houtman and L. E. Samelson, unpublished results). For
RBL cells, we know of no determination of these concentra-
tions. These values are listed in Table 3. Grb2, through its
SH2 or SH3 domains, can bind to numerous signaling mole-
cules besides SOS1 (32). Thus, its concentration listed in
Table 3 is an upper bound on the concentration of Grb2
available to interact with SOS1.
EQUILIBRIUM THEORY
To develop the equilibrium theory, we follow the same
approach as Perelson and Goldstein (19). We enumerate
and assign the correct statistical weights (the relative concen-
TABLE 3 Estimated cellular concentrations
Parameter
Jurkat E6.1 human
T cells (molecules/cell)
RBL-2H3 cells
(molecules/cell)
LT 1.1  0.1  106 1.1  0.1  106
GT 1.3  0.4  106 ND
ST 1.3  0.4  105 ND
The concentrations of LAT in the two cell lines are unpublished results
determined by I. Reischl and H. Metzger. The concentration of Grb2 and
SOS1 in Jurkat cells are unpublished results determined by J. C. Houtman
and L. E. Samelson.Biophysical Journal 96(7) 2604–2623trations) to all possible complexes involving Grb2, SOS1,
and LAT. The sum of these weights is the partition function.
From the partition function, we can easily obtain the conser-
vation laws for Grb2, SOS1, and LAT, the solution of which
yields their free concentrations. Knowing these quantities,
we can calculate all quantities of interest.
Bivalent LAT
We start by considering a homogeneous population of biva-
lent LAT, i.e., each LAT has only two of its three Grb2
binding sites phosphorylated, so that only linear chains of
LAT can form. In Fig. 3, all linear chains that begin and
end with a LAT with one site free are shown. For linear
chains of the form shown in Fig. 3, the equilibrium concen-
tration of a complex of two LATs cross-linked by a Grb2-
SOS1-Grb2 is 4KGLCKGLL
2, whereas the equilibrium
concentration of a complex of n LATs cross-linked by n-1
Grb2 dimers is ð4KGLCKGLLÞn1L. Each end of a linear
chain can be unbound, or bound to a single Grb2, a Grb2-
SOS1, or a Grb2-SOS1-Grb2. The concentration of all
complexes containing only one LAT can be written as E2L
and the concentration of complexes containing n LATs as
E2ð4KGLCKGLLÞn1L, where
E ¼ 1 þ KGLG þ 2KGLKGSGS þ 2sKGLK2GSG2S
¼ 1 þ b: (4)
We will use the notation that Wn is the concentration of
LAT molecules that are in aggregates of size n, i.e., in aggre-
gates that contain n LAT molecules, and that wn ¼ Wn/LT.
We denote the fraction of all species containing only one
LAT by w,
wh w1 ¼ ð1 þ bÞ2l: (5)
The fraction of LAT in aggregates having n LATs is
wn ¼ ð1 þ bÞ2ð4KGLCKGLLÞn1l
¼
 
4KGLCKGLLT
ð1 þ bÞ2
!n1
wn: (6)
It is useful to introduce the following nondimensional
parameters:
a ¼ 3KGLLT; c ¼ 2KGLC; (7)
c ¼ KGLGT; m ¼ 2KGSST; q ¼ KGSGT: (8)
FIGURE 3 For bivalent LAT, the partition function Ql0 for linear chains
that begin and end with a LAT with one site free. Solid circles indicate phos-
phorylated Grb2 binding sites on LAT.
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wn ¼ ð2d=3Þn1wn; (9)
where
d ¼ 6KGLCKGLLTð1 þ bÞ2 ¼
ac
ð1 þ bÞ2: (10)
We can now obtain the normalized partition function ql,
which we define as the sum of the fractional concentrations
of all LAT-containing species, i.e.,
q1 ¼w þ ð2d=3Þw2 þ ð2d=3Þ2w3 þ /
¼ w
1 ð2=3Þdw ¼ 1: ð11Þ
To obtain the conservation laws for LAT, Grb2, and SOS1
we note that each term in ql is of the form Ui,j,kS
iGjLk/LT,
where i, j, and k are the number of SOS1, Grb2, and LAT
molecules in the species and Ui,j,k is a statistical weighting
factor. Recognizing this, we can, for example, express the
conservation law for SOS1 as
VST ¼ VðS þ C þ 2KGSGSÞ þ ALT
PN
i;j;k
iUi;j;kS
iGjLk
¼ VðS þ C þ 2KGSGSÞ þ ALTSvq1vS ; ð12Þ
where the terms multiplied by V represent the concentrations
of SOS1 and its complexes in solution and the terms multi-
plied by A represent the concentrations of SOS1 in
complexes with LAT at the surface. In terms of the nondi-
mensional parameters, Eq. 7, the conservation laws can be
written as
l

vq1
vl

¼ w

vq1
vw

¼ 1; (13)
g þ mgs þ smqg2s þ

ALT
VGT

g

vq1
vg

¼ 1; (14)
s þ 2qgs þ sq2g2s þ

ALT
VST

s

vq1
vs

¼ 1: (15)
The same conservation laws hold for trivalent LAT when
ql is replaced by q, the partition function, which is the sum
of the fractional concentrations of all aggregates that can
be formed with trivalent LAT.
Trivalent LAT
Linear chains
We now obtain expressions for the concentrations of all
aggregates that can form among LAT, SOS1, and Grb2
when LAT has three binding sites for Grb2. Once this is
done, we can obtain the partition function, q, and then, the
conservation laws by replacing ql with q in Eqs. 13–15.
We start by considering all linear chains that contain twoor more LAT molecules. It is instructive to consider the
linear chain of LATs shown on the right side of the reaction
in Fig. 2 a. Note that for this chain the interior LATs have
one free site each and each of the two LATs at the ends of
the chain has two free sites. As discussed for the bivalent
case, in general, the binding sites on LAT not involved in
cross-linking can be free, or bound to Grb2, or Grb2-
SOS1, or Grb2-SOS1-Grb2. Thus, we expect the concentra-
tion of all linear chains containing n LATs to be proportional
to Enþ2¼ (1þ b)nþ2 for nR 2, where E is defined by Eq. 4.
We show in Appendix A that the sum of the concentrations
of all linear chains (n R 2) is
Q0 ¼ 9KGLKGLL2Cð1 þ bÞ4

1 þ 12KGLKGLCð1 þ bÞL
þ ð12KGLKGLCð1 þ bÞLÞ2þ/

; ð16Þ
where b is given by Eq. 4. We define the dimensionless
linear chain partition function as q0 ¼ Q0/LT.
q0 ¼ 3
2
l2acð1 þ bÞ41 þ 2acð1 þ bÞl
þ ð2acð1 þ bÞlÞ2þ/: (17)
The above equation can be rewritten as
q0 ¼ 3
2
ac
ð1 þ bÞ2

lð1 þ bÞ32
 
1 þ 2acð1 þ bÞ2lð1 þ bÞ
3
þ
 
2ac
ð1 þ bÞ2lð1 þ bÞ
3
!2
þ/
!
: ð18Þ
For trivalent LAT, the fraction of all LAT molecules not in
aggregates with other LAT is
w ¼ L
LT
ð1 þ bÞ3¼ lð1 þ bÞ3: (19)
Recall that for bivalent LAT, w is given by Eq. 5. With the
above expression for w and the definition of d, Eq. 18 can
be rewritten as
q0 ¼ 3
2
dw2

1 þ 2dw þ ð2dwÞ2þ/ ¼ 32dw2
1 2dw: (20)
Branched chains
To obtain the partition function, q, which includes both
linear and branched structures, we follow the procedure for
counting aggregates used by Goldstein and Perelson (19).
We only give a brief outline of the method. (For references
and details, see (19).) As discussed at the end of Modeling
of LAT Oligomerization, we only consider structures that
do not contain rings. In graph theory, these are called
‘‘trees’’. The method starts by considering a subset of all
trees called ‘‘planted-plane’’ trees. As its name implies,
a planted-plane tree is a tree with one end, its root, distin-
guished from all other ends. Goldstein and Perelson (19)Biophysical Journal 96(7) 2604–2623
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weight to molecular aggregates that contain no loops is to
first count and weight planted-plane trees and then to correct
for the degeneracy that arises by having chosen one partic-
ular end at which to begin the counting. The procedure to
enumerate and weight all possible trees, starts by defining
a planted-plane tree of order zero as a linear chain, and a
planted-plane tree of order one as a linear chain or
a planted-plane tree with a single branch point (see Fig. 3
in (19)). A planted-plane tree of order k is defined to be either
a linear chain or a planted-plane tree that starts with a linear
chain and then bifurcates into two planted trees that are each
of order k  1. Defined in this way, a planted-plane tree of
order k is the sum of all trees of all orders up to, and
including, k. Thus, in the limit that k / N, all possible
planted-plane trees are represented.
All planted-plane trees start with a linear chain whose
rooted end has two Grb2 binding sites that are not cross-
linked to another LAT. These may be free (as, for example,
the leftmost ends of the linear chains in Fig. 2) or bound (to
Grb2, Grb2-SOS1, or Grb2-SOS1-Grb2). To form a branch
point, we start by considering a linear chain with one end
rooted and the other end having a LAT with two unoccupied
Grb2 binding sites. Chains of all lengths with these ends
contribute a term q0/(1 þ b)2 to the partition function. (We
divide by (1 þ b)2, because the chains we consider have
one end with two free sites, while q0 is the sum of concentra-
tions for all possible linear chains.) A branch point is formed
at the end of a chain when the reaction in Fig. 2 c is followed
by the reaction in Fig. 2 d. The equilibrium concentration
of the Grb2-SOS1-Grb2-LAT species is 6KGLLC. Hence,
the binding of a Grb2-SOS1-Grb2-LAT ligand to the
first Grb2 binding site (Fig. 2 c) contributes a term
2KGLð6KGLLCÞ to the partition function, while the binding
to the second Grb2 binding site on LAT contributes a term
ðKGL=2Þð6KGLLCÞ (Fig. 2 d with rx ¼ 1). Thus, for a linear
chain with a branch point leading to two LAT molecules,
one obtains the nondimensional partition function
ðq0=ð1þ bÞ2ÞK2GLð6KGLLCÞ2. To count all planted plane
trees with a single branch point, we need to allow the two
arms that bifurcate from the linear planted chain to be of arbi-
trary length, and to allow the two Grb2 binding sites on each
of the two LAT molecules at the ends of the two arms to be
either free or bound. Formally, we do this by replacing
6KGLLC with q0=ðð3=2ÞKGLlð1þ bÞ2Þ. Consequently, q1,
the partition function for a tree of order 1, is given by
q1 ¼ q0 þ q
3
0
3
2
lð1 þ bÞ32 ¼ q0

1 þ gq20

; (21)
where the branching parameter g is defined as
g ¼ 1
3
2
lð1 þ bÞ32: (22)Biophysical Journal 96(7) 2604–2623Using Eq. 19, g can be rewritten as
g ¼ 1
3w
2
2: (23)
Equation 21 is identical in form to Eq. 8 in Goldstein and
Perelson (19), and thus, the derivation of the full partition
function that follows from this equation holds as well. There-
fore, from Goldstein and Perelson (19) we have
q ¼ w þ 1
gq0
"
1 1

1 4gq20
3
2
6gq20
#
: (24)
Given the functional forms of w, g, and q0, q can be ex-
pressed as a function of the concentrations g, s, and l, which
can be determined by solving the conservation equations,
Eqs. 13 and 14.
Concentration of LAT aggregates containing n receptors
We are interested in obtaining the LAT aggregate size distri-
bution for any set of concentrations of Grb2, SOS1, and
LAT. Recall that we have denoted the fractional concentra-
tion of aggregates containing n LAT by wn and for n ¼ 1
we have set w1 h w. For n R 2, we obtain, in Appendix
B, a general expression for wn,m, the fractional concentration
of aggregates containing n LAT and m branch points. Then,
for nR 2, wn ¼
Pmmax
m¼0 wn;m, where wn, m and mmax are given
by Eqs. 59 and 62 in Appendix B. To illustrate, we evaluate
wn for LAT aggregates up to hexamers, i.e., n ¼ 6. From Eq.
62, the values ofmmax for (n¼ 2, 3), (n¼ 4, 5), and n¼ 6 are
0, 1, and 2, respectively:
w1 ¼ w; (25)
w2 ¼ w2;0 ¼ ð3=2Þdw2; (26)
w3 ¼ w3;0 ¼ 3d2w3; (27)
w4 ¼ w4;0 þ w4;1 ¼ 6d3w4 þ d3w4 ¼ 7d3w4; (28)
w5 ¼ w5;0 þ w5;1 ¼ 12d4w5 þ 6d4w5 ¼ 18d3w5; (29)
and
w6 ¼ w6;0 þ w6;1 þ w6;2 ¼ 24d5w6 þ 24d5w6
þ ð3=2Þd5w6 ¼ ð99=2Þd5w6: ð30Þ
It should be noted that the wn, 0 values obtained from Eq. 59
refer to linear chains containing n LAT molecules and hence
are identical to the terms in the expansion of q0 in Eq. 20.
The average size of a LAT aggregate containing two or
more LAT molecules is given byPN
n¼ 2 nwnPN
n¼ 2 wn
¼ w
vq
vw
 w
q w ¼
1 w
q w: (31)
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To directly test whether LAT oligomerization plays a role in
signaling, Houtman et al. (15) inhibited LAT oligomeriza-
tion in Jurkat E6.1 cells by expressing a C-terminal fragment
of SOS1 (CSOS1) that contained a single C-terminal proline-
rich domain. The fragment bound the Grb2 with a 1:1
stoichiometry so that the Grb2-CSOS1 complex could not
bridge two LAT molecules. The expression of the SOS1
fragment reduced the size of clusters of phosphorylated
LAT and the activation of downstream signaling pathways.
We add CSOS1 to the model by first defining IT and I as
the total and free concentrations of CSOS1. We let
i ¼ I=IT (32)
and
h ¼ KGSIT: (33)
In the presence of CSOS1, the resulting Grb2-CSOS1
complex acts as a chain terminator, as it cannot bridge two
LAT molecules. Hence, to account for the presence of
CSOS1, we replace b in Eq. 4 by
bI ¼ KGLGþ 2KGLKGSGSþ KGLKGSGI þ 2sKGLK2GSG2S
¼ cg þ cmgs þ chgm þ scmqg2s: ð34Þ
When CSOS1 is present, the partition function is still given
by Eq. 24 but with b in the expressions for q0, g, and w re-
placed by bI. Calling the partition function for LAT qI when
the inhibitor CSOS1 is present, the conservation equations
for LAT, Grb2, SOS1, and CSOS1 become
l

vqI
vl

¼ 1; (35)
g þ mgs þ hgi þ smqg2s þ

ALT
VGT

g

vqI
vg

¼ 1;
(36)
s þ 2qgs þ sq2g2s þ

ALT
VST

s

vqI
vs

¼ 1; (37)
i þ qgi þ

ALT
VIT

i

vqI
vi

¼ 1: (38)
Solving Eqs. 35–38 yields g, s, l, and i, which in turn can be
used to determine the size distribution of LAT aggregates
and the average LAT aggregate size in the presence of
CSOS1.
Formation of a gel-like phase for trivalent LAT
When bivalent LAT interacts with a bivalent ligand, only
linear aggregates can form and no gel-like state is possible
(19). However, for trivalent LAT, where branched aggre-gates can form, the possibility arises that a gel-like state,
i.e., a superaggregate, can form.
We define M1 and M2 as the first and second moments,
respectively, of the trivalent LAT aggregate distribution.
Then,
M1 ¼
XN
n¼ 1
nwn ¼ wvq
vw
(39)
and
M2 ¼
XN
n¼ 1
n2wn ¼ w v
vw

w
vq
vw

: (40)
The first moment is the fraction of trivalent LAT in finite-
sized aggregates. In the absence of infinite aggregates,
M1 ¼ 1, which is tantamount to the conservation law for
trivalent LAT. The second moment is the average size of
all entities containing trivalent LAT. Consider now a situa-
tion where we can vary the concentration of LAT. Below
a certain critical value of LAT, all the aggregates are finite.
It is possible, however, that for appropriate concentrations
of SOS1 and Grb2, when the LAT concentration is increased
beyond the critical value, a superaggregate will form. In
increasing LAT, one has gone from a pure sol phase where
only finite size aggregates are present, to a phase where sol
and gel (a superaggregate) coexist. At the gel point where
the transition occurs, M1 ¼ 1 but M2 diverges, indicating
the presence of superaggregates. In the sol-gel region,
M1 < 1, and 1  M1 is the fraction of LAT in the gel phase.
Using the conditions that M1 ¼ 1 and M2 blows up at
the boundary between of the sol-gel region, we show in
Appendix C that the following three equations hold at the
boundary:
gþ mgsþ smqg2sþ 3
2

ALT
VGT
 
1þ
gðvb
vg

g
ð1 þ bÞ
!
¼ 1;
(41)
sþ 2qgsþ sq2g2sþ 3
4

ALT
VST
 
1þ 2s
ðvb
vs

s
ð1 þ bÞ
!
¼ 1;
(42)
2 ascmqg
2s
ð1 þ cg þ cmgs þ scmg2sÞ2 ¼ 0: (43)
Given the total number of LAT and Grb2 molecules
present in the system, we can use the above three equations
to predict whether gel formation is possible and if it is, over
what range of SOS1 concentrations the superaggregate
formation can occur. Equations 41–43 can be simultaneously
solved for g; s; and STgf . For some values of GT and LT
these three equations have no physically acceptable roots,
indicating that for these values of GT and LT there is noBiophysical Journal 96(7) 2604–2623
2612 Nag et al.concentration of SOS1 forwhich gel-like aggregates can form.
For the GT; LTgf pair at which gel-formation is possible, we
obtain twophysically acceptable solution sets of g; s; STgf ,
which correspond to the boundaries in GT; LT; STgf param-
eter space where the gel-formation sets in. Given the
GT; LTgf values, the higher ST value corresponding to a gel
point we denote by SuT, and the lower ST value corresponding
to a second gel point we denote by SlT. Thus, along the line
segment in the parameter space joining the points
GT; LT; S
1
Tg

and GT; LT; S
u
Tg

, we have small aggregates
of LAT coexisting with a gel-like phase (see Fig. 7 a).
We can also calculate the fraction of LAT molecules in the
gel-like phase (fg). To determine this quantity, we assume as
in Goldstein and Perelson (19) that the theoretical framework
for describing the LAT aggregates in the absence of the
gel-phase is still valid for the LAT aggregates comprising
the sol phase in the presence of the gel phase. With this
assumption, Eqs. 41 and 42 remain valid throughout the
gel phase whereas Eq. 43 holds only at the boundary. We
find in Appendix D that the fraction of the total number of
LAT molecules in the gel phase is given by
fg ¼ 1 2ð1 þ bÞ
2
ascmqg2s
: (44)
Once we have the SlT and S
u
T values for a given GT; LTgf
pair, we can solve Eqs. 41 and 42 for g and s, using values
of ST between S
l
T and S
u
T, and keeping GT and LT fixed at
the values for which SlT and S
u
T have been evaluated. These
solutions in g and s not only yield the gel-phase fraction fg
from Eq. 44, but as shown in Appendix D, ws, the fraction
of LAT in the sol phase that is not in aggregates:
wS ¼ 1
2
 3ð1 þ bÞ
2
4ascmqg2sfS
: (45)
Using the above expression of ws, we can calculate the
aggregate size distribution of the sol phase following the
procedure outlined in Appendix D.
STOCHASTIC SIMULATIONS
To simulate LAT-Grb2-SOS1 interactions numerically, we
use a recently developed rule-based, kinetic Monte Carlo
approach (22). A detailed description of the application of
the method to the LAT-Grb2-SOS1 model is provided
in the Supporting Material. Here, we present an overview.
The main advantage of the rule-based kinetic Monte Carlo
approach over standard methods for simulation of stochastic
dynamics of biochemical systems (33,34), is that it avoids the
combinatorial explosion of the number of possible species
and reactions that arises from the interactions of multivalent
molecules (35,36). In particular, dynamical simulation of
LAT aggregation in the gel phase regime would be impos-
sible using conventional chemical kinetics methods because
the number of equations that would need to be integrated isBiophysical Journal 96(7) 2604–2623effectively infinite. This combinatorial complexity can be
overcome, however, by assuming that the number of distinct
reaction types is much smaller than the number of possible
interacting species (an assumption that matches our current
technological limitations in measuring biochemical reaction
rates), and by simulating the system as a set of discrete
objects rather than using continuum equations (as in the
conventional formulation using ordinary differential equa-
tions). Rules are introduced that describe how reactivity
depends on the identity of interacting sites, the local context
of interacting molecules (e.g., the binding or modification
states of neighboring sites), and whether the reactants are
in solution or tethered to a membrane. For each rule, corre-
sponding lists of the possible reactive sites in the system are
maintained. For rules describing unimolecular transforma-
tions, e.g., dissociation of a bond or phosphorylation, a single
reactant list is maintained, whereas for rules describing
bimolecular association, two lists are maintained. Cumula-
tive reaction rates for each rule are calculated as a function
of the rate constant for the rule and the size of the reactant
list or lists. The system is then simulated using an extended
version of the Gillespie direct method (33,34), which
includes additional steps for selecting the specific molecules
and sites undergoing reaction and for rejecting reactions if
the reactants fail to meet additional criteria (22). At each
step in the simulation, the size of the next time step and
the next reaction to occur are selected using Gillespie’s direct
method. Reactant sites are then chosen at random among the
sites available to react. If the chosen reactants satisfy any
additional reaction criteria (e.g., that the reactant sites may
not belong to the same complex), the transformation speci-
fied by the rule is applied to the reactants and the reactive
sites lists are updated. In addition to lists involving sites
directly affected by the rule, lists associated with adjacent
sites may also require updates. The largest number of lists
that must be updated for the current model is three (see Sup-
porting Material). The simulation then continues until the
end time is reached or some other stopping criterion is satis-
fied. Previous work has shown that the method is accurate
and efficient for simulating the dynamical and steady-state
properties of the sol-gel phase transition for a system of triva-
lent ligands and bivalent receptors (22).
The simulations are used to track the aggregate size distri-
bution in time. The final output is obtained by averaging the
data over multiple runs. The system size is set to the total
number of molecules, and it can also be rescaled by multi-
plying bimolecular rate constants by a volume factor, Fx,
and dividing LT, GT, and ST by Fx.
RESULTS
In this section we present results obtained from the equilib-
rium model and stochastic simulations. Agreement between
the two gives us confidence in the theory and the simulation
method.
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In Fig. 4 a, we compare the predicted average size of an
aggregate of LAT molecules as a function of either bivalent
or trivalent LAT concentration, when the concentrations of
Grb2 and SOS1 are those estimated for a Jurkat E6.1 cell
(Table 3). The upper and lower solid lines are the predicted
values from the equilibrium theory for trivalent and bivalent
LAT. The dashed line is for a trivalent LAT concentration
that is two-thirds that of the upper curve and therefore has
the same number of Grb2 binding sites as the dimer curve.
The open circles and triangles are predicted from simulation
and are in excellent agreement with the theory. We see that
for trivalent LAT, the average aggregate size goes through
a maximum and then decreases with increasing LAT
concentration. For high enough values of LAT, this follows,
because as LT/N, all LAT aggregates become dimers. As
expected, trivalent LAT forms larger aggregates than diva-
lent LAT at the same LAT concentrations. However, for
the Grb2 and SOS1 concentrations used in Fig. 4 a, there
is no dramatic difference in aggregate size. The ratio of
Grb2 to SOS1 is 10:1, which is far from the optimal value
for maximizing LAT aggregation. If the ratio of Grb2 to
SOS1 is >>2, there will be a large pool of Grb2 not bound
to SOS1 that can bind to LAT and block aggregation. In
Fig. 4 b we plot the quantity x (Eq. 65), which is a measure
of how close the system is to the gel point. In Appendix C
we show that xR 1 with x ¼ 1 at the gel point. We assume
that throughout the region where the sol and gel coexist, x ¼
1. (We shall see that simulations agree with the predictions
of the theory in the sol-gel region and therefore support this
assumption.) As we see in Fig. 4 b, x is minimal but not
equal to one when trivalent LAT aggregation is maximal.
As the LAT concentration is increased further, the average
LAT aggregate size decreases and x diverges from one.
We consider a second case in Fig. 4 c, taking the ratio ofGrb2 to SOS1 to be 2:1 with the Grb2 concentration reduced
approximately to one-half of that used in Fig. 4 a. Here we
see a significant difference between the average aggregate
size formed by bivalent and trivalent LAT, with the average
aggregate size growing much more rapidly for trivalent than
bivalent LAT as the LAT concentration is increased. This is
because, for the concentrations of Grb2 and SOS1 we have
chosen in Fig. 4 c, the gel point is reached when LT ¼ 5.758
 104 trivalent LAT/cell. As we noted earlier, superaggre-
gate formation does not occur for bivalent LAT. Thus, for
appropriate concentrations, switching the valence of LAT
from two to three can dramatically increase the size of the
aggregates of LAT that form.
Properties of the sol-gel coexistence region
We next look in more detail at the formation of gel-like
superaggregates in a homogeneous population of trivalent
LAT. Given the total concentrations of Grb2 and SOS1,
we can solve Eqs. 41–43 for g*, s*, and LT. There will either
be two solutions or none. If there are none, then for the
values of the Grb2 and SOS1 concentrations chosen there
is no LAT concentration for which sol and gel coexist. If
there are two solutions, the two values of LT correspond
to the lowest and highest concentrations of LAT at which
superaggregation can occur. For GT ¼ 7.5  105 and
ST ¼ 3.75  105, the first gel point occurs when LT z
5.758  104. As LT is increased beyond this value, a gel-
like superaggregate coexists with the sol phase comprising
smaller LAT aggregates, as indicated by simulation results
in Fig. 5, a and b. In the sol phase, we expect good agreement
between theory and simulation for the predicted fractional
LAT aggregate size distribution, unless the reduction in
system size is so large as to prevent formation of aggregate
sizes that have a significant probability of forming in the un-
reduced system. In Fig. 5 a, the agreement between theorya c
b d
FIGURE 4 (a) Predicted average aggregate size for bi-
and trivalent LAT when the number of Grb2 and SOS1
molecules per cell are those estimated for Jurkat E6.1 cells,
GT ¼ 1.3  106 molecules/cell and ST ¼ 1.3  105 mole-
cules/cell. (a and c) Open circles (trivalent LAT) and open
triangles (bivalent LAT) are simulation results. The solid
curves in panels a and c were obtained by solving Eqs.
13–15 simultaneously and then calculating the average
aggregate size from Eq. 31. The dashed lines are for a triva-
lent LAT concentration that is two-thirds that of the upper
curve and therefore has the same number of Grb2 binding
sites as the dimer curve. (b) The quantity x ¼ (1  2dw)/
(2dw) for the same set of concentrations of Grb2 and
SOS1 used in panel a. The quantity x is a measure of
how close the system is to the sol-gel coexistence region.
At the gel point, x ¼ 1. (c) Predicted average aggregate
size for bi- and trivalent LAT when number of Grb2 and
SOS1 molecules per cell were 7.5  105 and 3.75  105,
respectively. (d) For the concentrations used in panel c,
the quantity x asymptotically approaches one with
increasing LAT concentration.Biophysical Journal 96(7) 2604–2623
2614 Nag et al.and simulation is excellent. In Fig. 5 b, gel formation is indi-
cated by the appearance of a peak in the LAT aggregate size
distribution at a large aggregate size. This contrasts with the
decaying tail of the distribution in Fig. 5 a, where the LAT
concentration is too low for superaggregate formation.
Again, for the sol phase, we get excellent agreement between
theory and simulation (see Appendix D for how the LAT size
distribution in the sol phase is calculated when sol and gel
coexist). In the simulations we define the number of LAT
molecules in the gel phase as the number of LAT in the
largest aggregate averaged over time, following an initial
equilibration period. The reduction in the system size in
the simulations reduces the size of the superaggregate
compared to the full system, but the predicted fraction of
LAT in the gel phase converges rapidly. For the parameters
a
b
c
FIGURE 5 Aggregate size distribution for trivalent LAT from theory
(solid lines) and simulation (solid circles), (a) below the gel point, (b)
in the sol-gel phase, and (c) above the gel point. (a–c) GT ¼ 7.5  105
and ST ¼ 3.75  105. (a) LT ¼ 3.0  104. (b) LT ¼ 2.0  105. (c) LT ¼
4.25  105. The appearance of a peak in the distribution at large aggregate
sizes in panel b corresponds to gel formation in the simulation system of
finite size. Each of the plots was generated by averaging over 30 simulations
taking Fx ¼ 100.Biophysical Journal 96(7) 2604–2623used in Fig. 5 b, theory predicts fg ¼ 0.74, and simulations
give a value of 0.71 for a value of Fx ¼ 100. The second
gel point occurs at LT z 3.926  105 LAT per cell. As
the simulations show in Fig. 5 c, at a concentration of
LAT higher than this, when LT ¼ 4.25  105, there is no
longer a gel phase.
Fig. 6 a shows the boundaries separating the sol region
from sol-gel coexistence regions, calculated from the equi-
librium theory, for four values of GT. As the Grb2 concentra-
tion decreases, the area of the sol-gel region decreases until,
below a critical value of Grb2 (GTz 2.6  105 Grb2/cell),
the two-phase region disappears. The three circles in Fig. 6 b
correspond to the three cases considered in Fig. 5, a–c, and
are consistent with Fig. 5 b having both a sol and gel phase.
In Fig. 6 c, the horizontal line corresponds to the estimated
SOS1 concentration in Jurkat E6.1 cells. Because the line
does not intersect a boundary, the model predicts for the
set of parameters we have chosen that a cell with the average
concentrations of a Jurkat E6.1 cell (Table 3) cannot form
superaggregates, no matter how much LAT is phosphory-
lated, given the current values of equilibrium constants.
However, the magnitude of the surface equilibrium cross-
linking constant KGL can strongly influence the size of the
sol-gel coexistence region and we have no experimental esti-
mate of this parameter. In Fig. S3, we show that for a value of
KGL that is 10 times higher than in Table 2, a small coexis-
tence region exists for trivalent LAT in the range LTz 5 
104 1.5 105 for the experimental value of SOS1 concen-
tration in Jurkat E6.1 cells. Further, there are other proteins,
such as c-Cbl (37) and HPK1 (38), that can bind to Grb2 and
cross-link LAT. These would effectively contribute to the
SOS1 concentration in our model.
In Fig. 7 a, we explore the properties of the sol-gel coex-
istence region by plotting contour lines for fg, the fraction of
LAT in the gel phase. The symbols indicate results from
simulation, whereas the contour lines are derived from the
equilibrium theory. In Fig. 7 b, we plot fg versus the number
of SOS1 per cell for a trivalent LAT concentration LT ¼ 2.0
 105, which corresponds to the vertical line in Fig. 7 a. The
solid line is the prediction from the equilibrium theory, while
the dotted line and the dashed line are simulation results for
Fx ¼ 100 and Fx ¼ 10. (Recall that Fx is the factor by which
the volume is reduced in the simulation.) For finite systems
there is no true transition from sol to sol plus gel, and this
is reflected in the way the simulated curves approach the
x axis. As the system size is increased (Fx is decreased),
a sharpening is seen and the deviation between simulation
and theory is reduced.
In Fig. 7 c, we plot fg versus the number of LAT per cell
for a SOS1 concentration ST¼ 2.0 105, which corresponds
to the horizontal line in Fig. 7 a. There is clearly a discrep-
ancy between the theory and simulation at the higher LAT
concentrations with the theory overestimating the amount of
LAT in the gel phase. Fig. 7 d shows the LAT aggregate
size distribution for LT ¼ 3.5  105 (open circle in Fig. 7 a),
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FIGURE 6 (a) Sol and gel coexis-
tence regions for four values of the
total Grb2 concentration: GT ¼ 1.3 
106, 7.5  105, 3.75  105, and
2.625  105 molecules/cell. The total
area of the sol-gel coexistence region
is a decreasing function of GT. (b)
Boundary of the sol-gel coexistence
region for GT ¼ 7.5  105. The hori-
zontal line corresponds to ST ¼ 3.75
 105. The open circles correspond to
the concentrations used in Fig. 5, a–c,
respectively. (c) The lower-left corner
of panel a is replotted. The horizontal
line corresponds to the SOS1 concen-
tration, ST ¼ 1.3  105 molecules per
cell, the estimated average value for
Jurkat E6.1 cells.where there is the largest deviation between predictions
from theory and simulation (Fig. 7 b). As can be seen, the
theory underestimates the concentration of LAT in the sol
phase (solid line) and overestimates the amount of LAT in
the gel phase. It is puzzling why the discrepancy between
theory and simulation occurs only at the large LAT
concentrations.
Kinetics of LAT aggregation in the absence
and presence of inhibitor
To inhibit LAT oligomerization, Houtmann et al. (15) tran-
siently expressed a C-terminal fragment of SOS1 in Jurkat
E6.1 cells that we refer to as CSOS1. This fragment could
form a 1:1 complex with Grb2, which could bind to phos-
phorylated Grb2 binding sites on LAT but could not
aggregate LAT (15). The cells were stimulated at two
concentrations of anti-CD3 antibodies, 0.02 mg/mL and 1.0
mg/mL, and Ca2þ influx measured. At the low stimulatingconcentration, the Ca2þ influx was reduced and its time
course was slowed. At the high stimulating concentration,
there was a very modest reduction in the level of the Ca2þ
influx with no change in the time course. This was presum-
ably because at high concentrations of phosphorylated LAT,
the monovalent inhibitor Grb2-CSOS1 could only block
a small fraction of the Grb2 binding sites on LAT. These
experiments lead us to introduce CSOS1 into our model to
assess its influence on LAT aggregation. In Fig. 8, we
compare LAT aggregation in the presence (dashed line)
and absence (solid line) of CSOS1 for two values of trivalent
LAT corresponding to low and high activation. For the low
value, a gel cannot form, whereas for the high value, it can.
In the simulations, the systems were allowed to equilibrate
before activated LAT was introduced.
At the low LAT concentration the inhibitor is highly effec-
tive, reducing the total amount of LAT in aggregates by
>70% (Fig. 8 c) and blocking the formation of essentially
all aggregates of LAT >2 (Fig. 8, a and b). At the higha b
c d
FIGURE 7 (a–d) GT ¼ 7.5  105. (a) Contour plots of
fg, the fraction of LAT molecules in the gel phase, from
theory and simulations. The boundary enclosing the sol-
gel region (solid line) is the same as in Fig. 6 b. In the
gel phase, four regions are shown that are characterized
by different theoretical ranges of fg. These are separated
by dotted, dashed and dotted-dashed lines. Symbols show
the simulation results: 0.05 < fg < 0.1 (crosses), 0.1 < fg
< 0.3 (dots), 0.3 < fg < 0.65 (open dots), and fg > 0.65
(stars). The simulation results were obtained using one
simulation run per pair of (LT, ST) values, with Fx ¼ 10.
(b) Comparison of theory and simulations for LT ¼ 2.0 
105 (vertical line in a). SlT and S
u
T in panel a are the
SOS1 concentrations at the gel points. The simulations
are for Fx ¼ 100 (dotted line), and Fx ¼ 10 (dashed
line). (c) Comparison of theory and simulations for
ST ¼ 3.75  105 (horizontal line in a). LlT and LuT are
the LAT concentrations at the gel points. As in panel b,
simulations are for Fx ¼ 100 (dotted line), and Fx ¼ 10
(dashed line). The solid circle corresponds to the
concentrations used in panel b and in Fig. 5 b. (d) LAT aggregate size distribution from simulation (dashed line) and theory (solid lines) for LT ¼ 3.5 
105 and ST ¼ 3.75  105 corresponding to the open circle in panel c. Simulations are for Fx ¼ 10.Biophysical Journal 96(7) 2604–2623
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FIGURE 8 LAT aggregation in the absence (solid line)
and presence (dashed line) of a SOS1 fragment that binds
only one Grb2 (CSOS1). The concentration of CSOS1 is
1.5  106, GT ¼ 7.5  105, and ST ¼ 3.75  105 mole-
cules/cell. In all panels, the solid and dashed lines are
predictions from the theory and the solid circles are simu-
lation results. (a–c) LT ¼ 2  104 molecules/cell and (d–f)
LT ¼ 2  105 molecules/cell. The simulations are the aver-
ages of 40 runs with Fx ¼ 100. (b, c, e, and f) Trivalent
LAT is introduced at t ¼ 100 s. The solid and dashed lines
are the predicted equilibrium values from the theory.LAT concentration, the inhibitor blocks the formation of the
gel phase as seen by the absence of the sharp peak in the LAT
aggregate size distribution (Fig. 8 d) and the dramatic reduc-
tion of LAT aggregate size (Fig. 8 e). However, there is
significant formation of small aggregates with a net reduction
of LAT aggregation of ~40%.
The kinetics of fully phosphorylated LAT aggregate
formation is fast (Fig. 8, b, c, e, and f), primarily because
Grb2-SOS1-Grb2 dimers are present in large concentrations
in the cytosol before the addition of activated LAT. The
inhibitor slows aggregation because it reduces the concentra-
tion of these dimers. It should be kept in mind that, in the
simulations, LAT phosphorylation is instantaneous, but in
an experiment, a number of steps must occur before LAT
becomes phosphorylated. Nevertheless, in Jurkat E6.1 cells,
phosphorylation of LAT tyrosine 191 was detected within
10 s after stimulation (26).
DISCUSSION
The scaffolding protein LAT plays a central role in both mast
cell and T cell signaling. When its three terminal tyrosines
are phosphorylated, they become binding sites for the
adaptor protein Grb2, which, through its SH2 domain, binds
to phosphorylated LAT, and through its two SH3 domains,
binds to the proline-rich regions of SOS1 (15). Two Grb2
molecules can bind to SOS1 to form a Grb2-SOS1-Grb2
dimer, which is capable of bridging two tyrosine-phosphor-Biophysical Journal 96(7) 2604–2623ylated LAT molecules. External stimuli, by controlling the
level of activation of Syk family kinases, modulate the
valence of LAT for Grb2 from zero to three. The formation
of large clusters of LAT has been observed in T cells after
T cell stimulation with anti-CD3 antibodies (16,15), and in
mast cells after the aggregation of IgE-Fc3RI complexes
(17,18).
We have presented a simplified model for Grb2-SOS1-
Grb2 mediated LAT oligomerization in homogeneous popu-
lations of either bi- or trivalent LAT and developed an
equilibrium theory for the model. The theory allows us to
determine the steady-state distribution of finite size aggre-
gates of LAT as well as the number of LAT in aggregates
and the average size of a LAT aggregate. To check the results
of the equilibrium theory, to account for finite size effects
and to extend our results to the kinetics of LAT aggregation,
we used a recently developed kinetic Monte Carlo method to
simulate the model (22). The simulations are in good agree-
ment with predictions of the equilibrium theory (see Figs. 4,
5, and 7), giving us confidence that the theory has been
correctly formulated for the model and that the simulation
method correctly simulates the model. We find that the
valence of LAT for binding Grb2, i.e., the number of LAT
phosphotyrosines that can bind the Grb2 SH2 domain, is
a critical factor in determining both the nature and extent
of aggregation (Fig. 4). If an external stimulus produces
substantial amounts of LAT that are trivalent for binding
Grb2 (a phenomenon we call ‘‘valence switching’’),
Modeling LAT Oligomerization 2617a dramatic rise in LAT oligomerization can occur, provided
the concentrations of LAT, Grb2, and SOS1 are properly
matched.
For a range of concentrations of Grb2, SOS1, and trivalent
but not bivalent LAT, the equilibrium theory predicts the
formation of Grb2-SOS1-Grb2 mediated superaggregates
of LAT and simulations agree with these predictions. The
range of concentrations over which this occurs corresponds
to a sol-gel coexistence region where the sol phase consists
of LAT monomers and small aggregates and the gel phase
consists of superaggregates of LAT (see Fig. 5). Such
a two-phase region appears to have been observed in stimu-
lated RBL-2H3 cells where Wilson et al. determined the
distribution of LAT clusters after cross-linking of Fc3RI-
bound IgE by the addition of a multivalent antigen (see
Fig. 8 in (17)). As early as 1 min after stimulation, a distribu-
tion of LAT aggregate sizes was observed with one aggre-
gate much larger than the rest. At 2 min after stimulation,
the outlying aggregate contained >160 LAT molecules.
Because the efficiency of labeling of LAT in the experiment
was not determined, 160 is a lower bound on the number of
LAT in the aggregate.
We mapped the predicted boundary of the region where
sol and gel coexist for a set of Grb2 concentrations (see
Fig. 6). Only for concentrations of SOS1 and trivalent
LAT within the sol-gel coexistence region, is superaggregate
formation predicted to occur. For a Grb2 concentration
<~2.6  105 Grb2/cell (~1.2  106 M for a Jurkat cell),
the model predicts that no superaggregate formation can
occur. In the model the only adaptor that can bind to SOS1
and form a dimer is Grb2, but at least one other adaptor,
Grap (Grb-2-like accessory protein), may do so as well.
Grap, which like Grb2 has a central SH2 domain flanked
by two SH3 domains, binds phosphorylated LAT through
its SH2 domain and SOS1 through at least one of its SH3
domains (39,40). The adaptor Gads binds phosphorylated
LAT at one and possibly two sites that are also binding sites
for Grb2 (8,24). However, it does not appear to bind to
SOS1, and thus it may act as a monovalent inhibitor of gel
formation, reducing the range of concentrations over which
superaggregate formation can occur.
The fraction of LAT that is in superaggregates, fg, depends
on the Grb2, SOS1, and LAT concentrations (see Fig. 7).
The theory and simulations predict that superaggregate
formation can occur when the trivalent LAT concentration
is in the range LTz 5  104  8  105 LAT/cell, providing
the Grb2 and SOS1 concentrations are also in the appropriate
ranges (Fig. 6). This means that even for an fg ¼ 0.10, we
predict 103–104 LAT in superaggregates. This is an overes-
timate, because the model considers only oligomerization
and includes no mechanisms that limit the size of aggregates.
Recently it has been shown for T cells that the ubiquitin
ligase c-Cbl, that can bind to LAT by first binding through
its proline-rich region to Grb2, can mediate the internaliza-
tion of LAT (41). In mutant cells lacking c-Cbl or transfec-tants with a mutant c-Cbl lacking its proline-rich domain,
LAT clustering persists for longer times than for the wild-
type (41).
Maintaining LAT aggregation in mast cells requires the
constant presence of activated Syk to phosphorylate binding
sites on LAT that become exposed through the dissociation
of Grb2. Dephosphorylation is blocked when an SH2
domain is bound to a phosphorylated site (42), but upon
dissociation the site is subject to rapid dephosphorylation
by membrane, and to a lesser extent, by cytosolic phospha-
tases (43). In RBL cells the intrinsic rate of dephosphoryla-
tion of an exposed phosphotyrosine has been estimated to be
20 s1, corresponding to a mean lifetime of 0.05 s (44).
When a multivalent antigen is used to aggregate IgE on
RBL cells, rapid phosphorylation of Fc3RI, Syk, and
LAT, as well as other proteins, occurs. Upon addition of
a high concentration of a monovalent hapten that blocks
receptor aggregation, receptor disaggregation follows,
accompanied by the dephosphorylation of the receptor,
Syk, and LAT, all with comparable half-lives of 10–15 s
(43,45). Although the extent of LAT aggregation was not
assayed in the experiments of Peirce and Metzger (45),
the rapid dephosphorylation of LAT indicates that LAT
aggregation is a highly reversible process. For the parame-
ters we have used (Table 2), this is true for the model as
well. If in the model we allow a superaggregate to form and
then, once steady state is established, introduce a dephosphory-
lation step with rate constant kd ¼ 20 s1, the superaggregate
breaks up in seconds (data not shown). In formulating the
model, we assumed that reactions that lead to the formation
of closed structures (loops) could be ignored. We expect that
including these reactions would at best marginally increase
the stability of aggregates because dephosphorylation is so fast.
Although it is clear that large aggregates of LAT form in
activated T cells and mast cells, what the role of these large
aggregates is, in cell signaling, remains a subject of debate.
One possibility is that large clusters of LAT enhance the
efficiency of LAT ubiquitylation mediated by c-Cbl and
the subsequent downregulation of LAT. If c-Cbl were in
low concentration compared to SOS1, c-Cbl would tend to
be found in large aggregates of LAT, where it would be in
proximity to multiple LAT molecules and the proteins asso-
ciated with LAT.
We have confined our discussion to the aggregation of
LAT by Grb2-SOS1-Grb2 dimers, but there are other trans-
membrane proteins that, when fully phosphorylated, have
valences R3 for Grb2 and where we might expect to see
similar large aggregate formation corresponding to a sol-
gel coexistence region. These include members of the
epidermal growth factor (EGF) family of receptors (46,47),
the non-T cell activation linker (NTAL) (48), and LAX
(49). Aggregation is ubiquitous in cell signaling, manifesting
itself at many levels. Carefully constructed models of aggre-
gation can contribute to our understanding of its multiple
roles in cell signaling.Biophysical Journal 96(7) 2604–2623
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In thisAppendix,we calculate the partition functionQ0 for the linear chains of
trivalent LAT molecules, cross-linked by the Grb2-SOS1-Grb2 species. The
equilibrium concentration of a linear chain with two LAT molecules, where
the two non-cross-linking sites on either LAT are free, is 9KGLKGLL
2C. To
include the contribution from linear chains in which any of the four non-
cross-linking sites on the two LAT molecules can be bound, we have to
multiply by E4, where E is defined in the bivalent LAT model (Eq. 4) as
E ¼ ð1 þ bÞ: (46)
The term E can be alternatively written as (1 þ b), where
b ¼ KGLG þ 2KGLKGSGS þ 2sKGLK2GSG2S: (47)
Thus, the contribution to the partition function of all chains with two LAT
molecules is 9 KGLKGLL
2Cð1þ bÞ4. The equilibriumconcentration of a linear
chain with three LAT molecules, where the five non-cross-linking sites on the
threeLATmolecules are free, is 108 K2GLK
2
GLL
3C2. To include the contribution
from linear chains in which any of the five non-cross-linking sites on the three
LAT molecules can be bound, we have to multiply by (1 þ b)5, so that the
contribution to the partition function of all chains with three LAT molecules
is 108 K2GLK
2
GLL
3C2ð1þ bÞ5. Similarly, it can be shown that the contribution
to the partition function of all linear chains with four LAT molecules is
1296 K3GLK
3
GLL
4C3ð1þ bÞ6, and so on. Hence, it results that
Q0 ¼ 9KGLKGLL2Cð1 þ bÞ4

1 þ 12KGLKGLCð1 þ bÞL
þ ð12KGLKGLCð1 þ bÞLÞ2þ.

: ð48Þ
APPENDIX B
In this Appendix, we obtain a general expression for wn,m that denotes the
nondimensional concentration of aggregates of n trivalent LAT molecules
with m branch points. From the literature (19,50), we obtainBiophysical Journal 96(7) 2604–2623where Q(z, x) is given by
Qðz; xÞ ¼ ð2gxq0Þ1

1 1 4gxq201=2: (51)
The x-integral can be performed by noting that the quantity
ð2piÞ1#Qðz; xÞxm1dx
in Eq. 50 equals the coefficient of xm in Q(z, x). Using Eq. 51 and the bino-
mial expansion
1 4gxq20
1
2 ¼ 1 1
2

4gxq20

 1:1
2:4

4gxq20
21:1:3
2:4:6

4gxq20
3.; (52)
one finds
ð2piÞ1#Qðz; xÞxm1dx ¼ 2q0 1:1:3:5:.ð2m1Þ
2:4:6:8:.ð2mþ 2Þ

4gq20
m
:
(53)
Substitution of this into Eq. 50 yields
qn;m ¼ 2:4m 1:1:3:5:.ð2m 1Þ
2:4:6:8:.ð2m þ 2Þð2piÞ
1#dzzn1gmq2mþ 10 :
(54)
We replacew by z in the definitions of q0 andg in Eqs. 20 and 22, respectively,
and substitute the resulting q0(z) and g(z) in the above equation to yield
qn;m ¼ 3
2
d2mþ 12:4m
1:1:3:5:.ð2m 1Þ
2:4:6:8:.ð2m þ 2Þ

h
ð2piÞ1#dzzðn2m2Þ1ð1 2dzÞð2mþ 1Þ
i
: ð55Þ
The z integral inside the square brackets in the above equation is the coeffi-
cient of z(n2m2) in (1  2dz)(2mþ1), which is given by (51)wn;m ¼ 2qn;mw
n
ðm þ 2Þ: (49)
In Wiegel and Perelson (50), the term qn,m is given by
qn;m ¼ ð2piÞ2# dz
znþ 1
#
dx
xmþ 1
Qðz; xÞ; (50)
Using the z integral from the above equation in Eq. 55, we get
or
qn;m ¼ 3
2
2n2m2dn1
ðm þ 1Þ
ð2mÞ!
m!m!
ðn 2Þ!
ð2mÞ!ðn 2m 2Þ!
¼ 3
2
2n2m2dn1
ðm þ 1Þ

2m
m

n 2
2m

: (58)
ð2dÞn2m2ð2m þ 1Þn2m2ðn 2m 2Þ! ¼ ð2dÞ
n2m2ð2m þ 1Þð2m þ 2Þ.ðn 2Þ
ðn 2m 2Þ! : (56)
qn;m ¼ 3
2
2n2m2dn122mþ 1 ð1:3:5.ð2m 1Þð2m þ 1Þð2m þ 2Þ.ðn 2ÞÞð2:4:6.ð2m þ 2ÞÞðn 2m 2Þ!
ð2:4:6.2mÞð2mÞ!
ð2:4:6.2mÞð2mÞ!
¼ 3
2
2n2m2dn122mþ 1
ð2mÞ!ðn 2Þ!
2mþ 1ðm þ 1Þ!ðn 2m 2Þ!2mm!ð2mÞ!
ð57Þ
Modeling LAT Oligomerization 2619Substituting the value of qn, m from the above equation in Eq. 49, we get
wn;m ¼ 2
n2m23dn1
ðm þ 1Þðm þ 2Þ

2m
m

n 2
2m

wn: (59)
For this equation to hold, nR 2. It is also evident from this equation that the
largest physically acceptable value of m for a given value of n should obey
the relation
n 2 ¼ 2m: (60)
The above equation can be rewritten as
m ¼ n 2
2
: (61)
It can be easily shown that for a given value of n, the largest possible value of
m is given by
mmax ¼
	
n 2
2


; (62)
where Pn2
2
R denotes the integer division (52) of n 2 by 2. Hence for nR 2,
the fraction of LATmolecules in aggregates of size n, wn can be expressed as
wn ¼
Xmmax
m¼ 0
wn;m: (63)
APPENDIX C
In this Appendix, we derive Eqs. 41–43. These equations characterize the gel
point.
Using the definitions of g (Eq. 22) and q0 (Eq. 20), the partition function q in
Eq. 24 can be written as
q ¼ w þ 3w

1 2dw
2dw


(
1 2
3

1 2dw
2dw
2
þ 2
3

1 2dw
2dw
2
1

2dw
1 2dw
232)
: ð64Þ
We define
x ¼ 1 2dw
2dw
: (65)
It has been shown in Fig. 4 d that x asymptotically approaches unity at the
gel point, and the farther the system is from the gel point, the larger the value
of x. The partition function q can be expressed in terms of x and w as
q ¼ w
"
1 þ 3x
(
1 2
3
x2 þ 2
3
x2

1 1
x2
3
2
)#
(66)
or
q ¼ w

1 þ 3x  2x3 þ 2x2  132: (67)
Then,
w
vq
vw
¼ w þ 3xw 2x3w þ x2  112	2wx2  1 3x
d


 3
2d
þ 3x
2
d
:
(68)The conservation equation for LAT can be written as
XN
n¼ 1
nwn ¼ wvq
vw
¼ 1: (69)
Substituting wvqvw from Eq. 68 in the above equation, we obtain
1 ¼ w
h
1 þ 3x  2x3 þ 2x2  1x2  112i
 3
2d
þ 3x
2
d
 3xðx
2  1Þ12
d
: ð70Þ
At the gel point M1 ¼ wvqvw ¼ 1, but because the large aggregates are preva-
lent,M2 ¼ w vvwðwvqvwÞ diverges. Hence, the values of w and d for whichM1¼
1 and M2/N, are the gel-point values.
Let us express M2 in terms of w and d. Equation 68 can be rewritten as
w
vq
vw
¼ w

1 þ 3x  2x3 þ 2x2  132
 3
2d
þ 3x
2
d
 3xðx
2  1Þ12
d
: ð71Þ
Using Eq. 67, the above equation can be written as
w
vq
vw
¼ q 3
2d
þ 3x
2
d
 3xðx
2  1Þ12
d
: (72)
Therefore,
w
v
vw

w
vq
vw

¼ wvq
vw
þ w
d
"
6x  3x2  112 3x2
ðx2  1Þ12
#
vx
vw
:
(73)
From Eq. 65, one can obtain
vx
vw
¼  1
2dw2
: (74)
From Eqs. 73 and 74, we get
w
v
vw

w
vq
vw

¼ wvq
vw
 3
2d2w
"
2x  2x
2  1
ðx2  1Þ12
#
: (75)
Using the conservation law (Eq. 69), we obtain
M2 ¼ w v
vw

w
vq
vw

¼ 1 3
2d2w
"
2x  2x
2  1
ðx2  1Þ12
#
: (76)
From the above equation, we find by observation that for x2 ¼ 1, M2/N.
Thus, at the gel point,
ðx þ 1Þðx  1Þ ¼ 0: (77)
The above equation in x has two roots of which only the positive root x¼ 1 is
physically acceptable. We adopt the general notation that any expression
with an asterisk as a superscript denotes the value of that expression at the
gel point. Thus, at the gel point,Biophysical Journal 96(7) 2604–2623
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From Eq. 65,
1 2dw
2dw
¼ 1: (79)
From Eq. 79, we get
dw ¼ 1
4
: (80)
At the gel point, M1 is still 1. Substituting x ¼ 1 in Eq. 70, we obtain
1 ¼ 2w þ 3
2d
(81)
or
w ¼ 1
2
 3
4d
: (82)
Substituting the value of w* from Eq. 82 into Eq. 80, we obtain
d ¼ 2: (83)
The conservation equations for g and s still hold at the gel point. Therefore,
from Eqs. 14 and 15, respectively, we get
g þ mgs þ smqg2s þ

ALT
VGT

g

vq
vg

g
¼ 1 (84)
and
s þ 2qgs þ sq2g2s þ

ALT
VST

s

vq
vs

s
¼ 1: (85)
From Eq. 67, we obtain
vq
vg
¼ vw
vg
h
1 þ 3x  2x3 þ 2x2  132i þ w	3vx
vg
 6x2vx
vg
þ 3x2  1122xvx
vg


: (86)
Similarly,
vq
vs
¼ vw
vs
h
1 þ 3x  2x3 þ 2x2  132i þ w	3vx
vs
 6x2vx
vs
þ 3x2  1122xvx
vs


: ð87Þ
At the gel point, x ¼ 1. Therefore, at the gel point, Eqs. 86 and 87, respec-
tively, yield 
vq
vg

g
¼ 2

vw
vg

g
3w

vx
vg

g
(88)
and 
vq
vs

s
¼ 2

vw
vs

s
3w

vx
vs

s
: (89)
Using the definitions ofw (Eq. 19) and d (Eq. 10), we canwrite fromEq. 65 that
x ¼ 1
2alcð1 þ bÞ  1: (90)Biophysical Journal 96(7) 2604–2623Taking the partial derivative of both sides of the above equation with respect
to g and multiplying both sides by g, we get
g
vx
vg
¼  1
alcð1 þ bÞ 
gvb
vg
2alcð1 þ bÞ2: (91)
From Eq. 80,
wd ¼ alcð1 þ bÞ ¼ 1
4
: (92)
Substituting the value of a*l*c*(1 þ b*) from Eq. 92 into Eq. 91, we obtain
for the gel point
g

vx
vg

g
¼ 4
2g

vb
vg

g
ð1 þ bÞ : (93)
From the definition of w, we obtain
vw
vg
¼ 3lð1 þ bÞ2vb
vg
¼ 3w
vb
vg
ð1 þ bÞ: (94)
Therefore at the gel point,

vw
vg

g
¼
3w

vb
vg

g
ð1 þ bÞ : (95)
We multiply both sides of Eq. 88 by g*, and substitute the expressions of
ðvw=vgÞg and gðvx=vgÞg from Eqs. 95 and 93, respectively, to yield
g

vq
vg

g
¼
6wg

vb
vg

g
ð1 þ bÞ þ 12w
 þ
6wg

vb
vg

g
ð1 þ bÞ
¼ 12w
2
641 þ g


vb
vg

g
ð1 þ bÞ
3
75: (96)
Now from Eqs. 82 and 83,
12w ¼ 12
	
1
2
 3
4d


¼ 3
2
; (97)
so that from Eq. 96, we obtain
g

vq
vg

g
¼ 3
2
2
641 þ g


vb
vg

g
ð1 þ bÞ
3
75: (98)
Along very similar lines, it can be shown that
s

vq
vs

s
¼ 3
4
2
41 þ 2s

vb
vs

s
ð1 þ bÞ
3
5: (99)
Substituting the values of gðvq=vgÞg and sðvq=vsÞs from Eqs. 98 and 99,
respectively, into Eqs. 84, we obtain Eqs. 41 and 42. Using Eq. 10, Eq. 83
can be rewritten as Eq. 43.
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In this Appendix, we derive the equations for the fraction of the total number
of trivalent LAT molecules in the gel phase.
Let the total number of LAT molecules present in the sol phase, i.e., as small
aggregates, be denoted by LS, and the fraction of the total number of LAT
molecules present in the sol phase by fs. Then, fs ¼ LS/LT, and the fraction
of total number of LAT molecules in the gel phase, fg, is given by 1 fs. We
define
aS ¼ 3KGLLS ¼ afs: (100)
From the definition of d (Eq. 10) it follows that
ds ¼ dfs: (101)
As mentioned in Formation of a Gel-Like Phase for Trivalent LAT, we
assume that the theoretical framework for describing the LAT aggregates
in the absence of the gel-phase is still valid for the LAT aggregates
comprising the sol phase in coexistence with the gel phase. Under this
assumption, the conservation equation for LAT in sol phase is obtained
by replacing w, d, and x in Eq. 70 by ws, ds, and xs, respectively,
wS

1 þ 3xS  2x3S þ 2

x2S  1

x2S  1
1
2

 3
2dS
þ 3x
2
S
dS
 3xS

x2S  1
1
2
dS
¼ 1; ð102Þ
where the fraction of LAT molecules in sol that are not in aggregates is
designated by ws, and
xS ¼

1 2dSwS
2dSwS

: (103)
To calculate ws, we need to know Ls or, equivalently, fs. This is equivalent to
finding an additional equation that describes the coexistence of sol and gel.
The equation that we choose is
xs ¼ 1: (104)
I.e., we assume that xs ¼ 1 holds throughout the sol-gel region, not simply
at the boundary of the sol-gel region. Because, xs ¼ 1 and the conservation
law (Eq. 102) are both assumed to hold in the two-phase sol-gel region,
ds satisfies Eq. 83. Substituting ds for d* in Eq. 83 and solving for fs, we find
fS ¼ 2ð1 þ bÞ
2
ascmqg2s
: (105)
Then the fraction of the total number of LAT molecules in the gel phase is
given by
fg ¼ 1 fs; (106)
so that we obtain Eq. 44. The assumption xs ¼ 1 is also tantamount to Eqs.
41 and 42 being valid not only at the gel points but also for the sol phase
coexisting with the gel. Hence, once we have the SlT and S
u
T values for
a given GT; LTgf pair, we can solve Eqs. 41 for g and s, using values of
ST between S
l
T and S
u
T, and keeping GT and LT fixed at the values for which
SlT and S
u
T have been evaluated. These solutions in g and s can not only
yield the gel-phase fraction fg from Eq. 44, but also the fraction of the total
number of LAT molecules in the sol phase that present in species containing
one LAT molecule. This fraction ws can be obtained fromwS ¼ 1
2
 3ð1 þ bÞ
2
4ascmqg2sfS
: (107)
The above equation is obtained by replacing w* and d* by ws and ds, respec-
tively, in Eq. 82, and then substituting ds by (ascmqg
2sfs/(1 þ b)2) using
Eqs. 10 and 101. The fraction of the total number of LAT molecules present
as species containing only one LAT molecule is given by
w ¼ wSfS ¼ fS
2
 3ð1 þ bÞ
2
4ascmqg2s
(108)
using Eq. 107. We estimate wn values for n R 2 as
wn ¼ fS
Xmmax
m¼ 0
wSn;m; (109)
where mmax is given by Eq. 62 in Appendix B, and w
s
n,m is obtained by
substituting w and d in Eq. 59 of Appendix B by ws and ds, respectively.
As shown by Fig. 5 b, the estimates show excellent agreement with simula-
tion results for the sol phase. The determination of wn for the sol phase, in
presence of the gel phase, enables us to define the average aggregate size
in presence of the gel phase. The average aggregate size is defined asPN
n¼2 nwn=
PN
n¼2 wn in Eq. 31. In presence of the gel phase, the above
expression can be approximated as ðPNn¼2 nwn þ fGÞ=ðPNn¼2 wn þ 1=LTÞ,
where N is the largest value of n for which nwnLTR 1. The value of N turns
out to be 1257 for the case in Fig. 8 e. In addition to contributions from the
sol phase, we consider the contribution fg, to
P
nwn, from a single aggre-
gate, the gel phase, of size (fgLT), and the contribution, 1/LT, to
P
wn to
obtain the final expression for the average aggregate size in presence of
the gel phase. It should be noted that the average aggregate size does not
change, for all practical purposes, on increasing the upper limit of the
summations beyond N.
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